Absorbable implants for plastic surgery
Absorbable implants for breast surgery that conform to the breast parenchyma and surrounding chest wall have been developed. These implants support newly lifted breast parenchyma, and/or a breast implant. The implants have mechanical properties sufficient to support a reconstructed breast, and allow the in-growth of tissue into the implant as it degrades. The implants have a strength retention profile allowing the support of the breast to be transitioned from the implant to regenerated host tissue, without significant loss of support. Three-dimensional implants for use in minimally invasive mastopexy/breast reconstruction procedures are also described, that confer shape to a patient's breast. These implants are self-reinforced, can be temporarily deformed, implanted in a suitably dissected tissue plane, and resume their preformed three-dimensional shape. The implants are preferably made from poly-4-hydroxybutyrate (P4HB) and copolymers thereof. The implants have suture pullout strengths that can resist the mechanical loads exerted on the reconstructed breast.
1. An implant for breast reconstruction or plastic surgery comprising a porous biodegradable scaffold, wherein the scaffold is prepared from a monofilament fiber made from a synthetic or biological polyester, wherein the scaffold can withstand a load of at least 5 N, more preferably at least 15 N, and even more preferably of at least 60 N.
2. The implant of claim 1 , wherein the implant has a three-dimensional shape that substantially represents the shape of the lower pole of the breast.
3. The implant of claim 1 , wherein the implant can extend up to 30% in one direction.
4. The implant of claim 1 , wherein the porous scaffold has a pore size of at least 10 μm.
5. The implant of claim 1 , wherein the scaffold can support a pressure of at least 0.1 kPa.
6. The implant of claim 1 , wherein the implant further comprises one or more bioactive agents, coatings including collagen and hyaluronic acid and derivative thereof, additives, and therapeutic, prophylactic or diagnostic agents, including antibiotics, antimicrobial agents, anti-inflammatory agents, radiopaque markers, and contrast agents.
7. The implant of claim 1 , wherein the scaffold comprises a monofilament mesh.
8. The implant of claim 1 , wherein the scaffold has a suture pullout strength greater than 10 N, and more preferably 20 N.
9. The implant of claim 1 , wherein the scaffold has an areal density of 5-800 g/m 2 .
10. The implant of claim 1 , wherein the implant retains at least 20% of its initial burst strength 12 weeks after implantation.
11. The implant of claim 1 , wherein the implant further comprises retainers, such as barbs and tacks.
12. The breast implant of claim 1 , wherein the breast implant is a silicone or saline implant.
13. The implant of claim 1 , wherein the implant further comprises tabs.
14. The implant of claim 1 , wherein the implant is suitable for use in conjunction with a tissue expander.
15. The implant of claim 1 , wherein the polyester is a polyhydroxyalkanoate.
16. The implant of claim 15 , wherein the polyhydroxyalkanoate is poly-4-hydroxybutyrate or copolymer thereof.
17. The implant of claim 1 , wherein the polyester comprises one or more of the following monomers: glycolic acid, glycolide, lactic acid, lactide, 1,4-dioxanone, trimethylene carbonate, 3-hydroxybutyric acid, and ε-caprolactone.
18. A breast reconstruction method comprising administration a breast implant at the site in need thereof, and the scaffold of claim 1 .
19. The method of claim 18 , comprising creating a pocket a pocket for the breast implant using the scaffold.
20. The method of claim 18 wherein the site comprises the major pectoralis muscle.